CSACI position statement: Newer generation H(1)-antihistamines are safer than first-generation H(1)-antihistamines and should be the first-line antihistamines for the treatment of allergic rhinitis and urticaria

Oral H(1)-antihistamines (AHs) are the most commonly used therapy to treat allergic rhinitis and chronic urticaria. Older, first-generation AHs (e.g. diphenhydramine, hydroxyzine) have significant and common side effects including sedation, impairment with decreased cognitive function, poor sleep qu...

Descripción completa

Detalles Bibliográficos
Autores principales: Fein, Michael N., Fischer, David A., O’Keefe, Andrew W., Sussman, Gord L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771107/
https://www.ncbi.nlm.nih.gov/pubmed/31582993
http://dx.doi.org/10.1186/s13223-019-0375-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771107/
https://www.ncbi.nlm.nih.gov/pubmed/31582993
http://dx.doi.org/10.1186/s13223-019-0375-9

Ejemplares similares